225 related articles for article (PubMed ID: 22808135)
1. Genome-wide detection of genes targeted by non-Ig somatic hypermutation in lymphoma.
Jiang Y; Soong TD; Wang L; Melnick AM; Elemento O
PLoS One; 2012; 7(7):e40332. PubMed ID: 22808135
[TBL] [Abstract][Full Text] [Related]
2. Over-expression of BACH2 is related to ongoing somatic hypermutation of the immunoglobulin heavy chain gene variable region of de novo diffuse large B-cell lymphoma.
Kikuchi T; Tokunaka M; Kikuti YY; Carreras J; Ogura G; Takekoshi S; Kojima M; Ando K; Hashimoto Y; Abe M; Takata K; Yoshino T; Muto A; Igarashi K; Nakamura N
Pathol Int; 2013 Jul; 63(7):339-44. PubMed ID: 23865571
[TBL] [Abstract][Full Text] [Related]
3. Determining the Origin of Human Germinal Center B Cell-Derived Malignancies.
Seifert M; Küppers R
Methods Mol Biol; 2017; 1623():253-279. PubMed ID: 28589362
[TBL] [Abstract][Full Text] [Related]
4. AID-associated DNA repair pathways regulate malignant transformation in a murine model of BCL6-driven diffuse large B-cell lymphoma.
Gu X; Booth CJ; Liu Z; Strout MP
Blood; 2016 Jan; 127(1):102-12. PubMed ID: 26385350
[TBL] [Abstract][Full Text] [Related]
5. Bach2 regulates AID-mediated immunoglobulin gene conversion and somatic hypermutation in DT40 B cells.
Budzyńska PM; Kyläniemi MK; Kallonen T; Soikkeli AI; Nera KP; Lassila O; Alinikula J
Eur J Immunol; 2017 Jun; 47(6):993-1001. PubMed ID: 28301039
[TBL] [Abstract][Full Text] [Related]
6. Genome-wide mutational signatures revealed distinct developmental paths for human B cell lymphomas.
Ye X; Ren W; Liu D; Li X; Li W; Wang X; Meng FL; Yeap LS; Hou Y; Zhu S; Casellas R; Zhang H; Wu K; Pan-Hammarström Q
J Exp Med; 2021 Feb; 218(2):. PubMed ID: 33136155
[TBL] [Abstract][Full Text] [Related]
7. Recurrent targets of aberrant somatic hypermutation in lymphoma.
Khodabakhshi AH; Morin RD; Fejes AP; Mungall AJ; Mungall KL; Bolger-Munro M; Johnson NA; Connors JM; Gascoyne RD; Marra MA; Birol I; Jones SJ
Oncotarget; 2012 Nov; 3(11):1308-19. PubMed ID: 23131835
[TBL] [Abstract][Full Text] [Related]
8. Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.
Hübschmann D; Kleinheinz K; Wagener R; Bernhart SH; López C; Toprak UH; Sungalee S; Ishaque N; Kretzmer H; Kreuz M; Waszak SM; Paramasivam N; Ammerpohl O; Aukema SM; Beekman R; Bergmann AK; Bieg M; Binder H; Borkhardt A; Borst C; Brors B; Bruns P; Carrillo de Santa Pau E; Claviez A; Doose G; Haake A; Karsch D; Haas S; Hansmann ML; Hoell JI; Hovestadt V; Huang B; Hummel M; Jäger-Schmidt C; Kerssemakers JNA; Korbel JO; Kube D; Lawerenz C; Lenze D; Martens JHA; Ott G; Radlwimmer B; Reisinger E; Richter J; Rico D; Rosenstiel P; Rosenwald A; Schillhabel M; Stilgenbauer S; Stadler PF; Martín-Subero JI; Szczepanowski M; Warsow G; Weniger MA; Zapatka M; Valencia A; Stunnenberg HG; Lichter P; Möller P; Loeffler M; Eils R; Klapper W; Hoffmann S; Trümper L; ; ; ; Küppers R; Schlesner M; Siebert R
Leukemia; 2021 Jul; 35(7):2002-2016. PubMed ID: 33953289
[TBL] [Abstract][Full Text] [Related]
9. Control of gene conversion and somatic hypermutation by immunoglobulin promoter and enhancer sequences.
Yang SY; Fugmann SD; Schatz DG
J Exp Med; 2006 Dec; 203(13):2919-28. PubMed ID: 17178919
[TBL] [Abstract][Full Text] [Related]
10. Immunoglobulin somatic hypermutation has clinical impact in DLBCL and potential implications for immune checkpoint blockade and neoantigen-based immunotherapies.
Xu-Monette ZY; Li J; Xia Y; Crossley B; Bremel RD; Miao Y; Xiao M; Snyder T; Manyam GC; Tan X; Zhang H; Visco C; Tzankov A; Dybkaer K; Bhagat G; Tam W; You H; Hsi ED; van Krieken JH; Huh J; Ponzoni M; Ferreri AJM; Møller MB; Piris MA; Winter JN; Medeiros JT; Xu B; Li Y; Kirsch I; Young KH
J Immunother Cancer; 2019 Oct; 7(1):272. PubMed ID: 31640780
[TBL] [Abstract][Full Text] [Related]
11. AID is expressed in germinal center B-cell-like and activated B-cell-like diffuse large-cell lymphomas and is not correlated with intraclonal heterogeneity.
Lossos IS; Levy R; Alizadeh AA
Leukemia; 2004 Nov; 18(11):1775-9. PubMed ID: 15385936
[TBL] [Abstract][Full Text] [Related]
12. A target selection of somatic hypermutations is regulated similarly between T and B cells upon activation-induced cytidine deaminase expression.
Kotani A; Okazaki IM; Muramatsu M; Kinoshita K; Begum NA; Nakajima T; Saito H; Honjo T
Proc Natl Acad Sci U S A; 2005 Mar; 102(12):4506-11. PubMed ID: 15767564
[TBL] [Abstract][Full Text] [Related]
13. Intraclonal diversity in follicular lymphoma analyzed by quantitative ultradeep sequencing of noncoding regions.
Spence JM; Abumoussa A; Spence JP; Burack WR
J Immunol; 2014 Nov; 193(10):4888-94. PubMed ID: 25311808
[TBL] [Abstract][Full Text] [Related]
14. Assessing somatic hypermutation in Ramos B cells after overexpression or knockdown of specific genes.
Upton DC; Unniraman S
J Vis Exp; 2011 Nov; (57):e3573. PubMed ID: 22083360
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide discovery of somatic regulatory variants in diffuse large B-cell lymphoma.
Arthur SE; Jiang A; Grande BM; Alcaide M; Cojocaru R; Rushton CK; Mottok A; Hilton LK; Lat PK; Zhao EY; Culibrk L; Ennishi D; Jessa S; Chong L; Thomas N; Pararajalingam P; Meissner B; Boyle M; Davidson J; Bushell KR; Lai D; Farinha P; Slack GW; Morin GB; Shah S; Sen D; Jones SJM; Mungall AJ; Gascoyne RD; Audas TE; Unrau P; Marra MA; Connors JM; Steidl C; Scott DW; Morin RD
Nat Commun; 2018 Oct; 9(1):4001. PubMed ID: 30275490
[TBL] [Abstract][Full Text] [Related]
16. Biased dA/dT somatic hypermutation as regulated by the heavy chain intronic iEmu enhancer and 3'Ealpha enhancers in human lymphoblastoid B cells.
Komori A; Xu Z; Wu X; Zan H; Casali P
Mol Immunol; 2006 Apr; 43(11):1817-26. PubMed ID: 16412510
[TBL] [Abstract][Full Text] [Related]
17. Recombinase-mediated cassette exchange as a novel method to study somatic hypermutation in Ramos cells.
Baughn LB; Kalis SL; MacCarthy T; Wei L; Fan M; Bergman A; Scharff MD
mBio; 2011; 2(5):. PubMed ID: 21990614
[TBL] [Abstract][Full Text] [Related]
18. Improved clonality assessment in germinal centre/post-germinal centre non-Hodgkin's lymphomas with high rates of somatic hypermutation.
Catherwood MA; Gonzalez D; Patton C; Dobbin E; Venkatraman L; Alexander HD
J Clin Pathol; 2007 May; 60(5):524-8. PubMed ID: 16816169
[TBL] [Abstract][Full Text] [Related]
19. Isotype-switched follicular lymphoma displays dissociation between activation-induced cytidine deaminase expression and somatic hypermutation.
Scherer F; Navarrete MA; Bertinetti-Lapatki C; Boehm J; Schmitt-Graeff A; Veelken H
Leuk Lymphoma; 2016; 57(1):151-60. PubMed ID: 25860234
[TBL] [Abstract][Full Text] [Related]
20. A critical context-dependent role for E boxes in the targeting of somatic hypermutation.
McDonald JJ; Alinikula J; Buerstedde JM; Schatz DG
J Immunol; 2013 Aug; 191(4):1556-66. PubMed ID: 23836058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
